This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Sepsis Diagnostics Market

Sepsis Diagnostics Market

Sepsis Diagnostics Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026

Sepsis Diagnostics Market
  • Jan-2018
  • List of Tables : 128
  • List of Figures : 102
  • 170 Pages
  • Healthcare


Sepsis is emerging as one of the leading causes of mortality around the globe. However, early detection can improve the outcomes, hence the demand for sepsis diagnostics is also rising.

Major companies in the market are also focusing on introducing technically advanced tools and techniques to provide sepsis diagnosis at an early stage.

Companies are also entering into mergers and acquisitions to carry research and development activity and expand globally.

New products are also being launched, while some products have already received the U.S. Food and Drugs Administration (FDA) clearance to be used for diagnosis purpose.

global sepsis diagnostics market

According to the new research by Fact.MR, the global market for sepsis diagnostics is likely to grow at a faster phase between 2017 and 2026.

The global market for sepsis diagnostics is also projected to bring in US$ 707.3 million revenue by 2026 end.

Assays & Reagents to Emerge as the Top-Selling Product

Among various products in sepsis diagnostics market, assays & reagents are likely to emerge as the top-selling products. Assays & reagents are projected to surpass US$ 300 million revenue by end of the forecast period.

Reagents and assays kits are showing lucrative growth due to the introduction of technically advanced tests by key players. Moreover, assays and reagents facilitate early diagnosis of sepsis.

Know More Details About the Report

Conventional Diagnostics to be the Most-Preferred diagnostic Method

Compared to the automated diagnostics, conventional diagnostics is likely to emerge as the most-preferred sepsis diagnosis method. Towards 2026 end, conventional diagnostics is projected to generate more than US$ 400 million revenue.

Conventional methods for diagnosis of sepsis is still the most-preferred one due to the low cost and it also leads to the timely changes to appropriate therapy.

Gram-positive Bacterial Sepsis to Hold the Largest Share on Basis of Pathogens Causing Septicemia

Gram-positive bacterial sepsis segment is likely to account for the maximum share in terms of revenue in the global market for sepsis diagnostics. Gram-positive bacterial sepsis are projected to reach close to US$ 300 million revenue by 2026 end.

Although bacteria causes sepsis on a large scale, the increase in sepsis is due to the gram-positive sepsis.

Various studies carried on sepsis are showing that gram-positive bacteria accounts for maximum septic shock and severe sepsis cases.

Moreover, the mortality rate due to gram-positive infection is high as compared to the gram-negative infection. Hence, therapeutic protocols are being undertaken to manage both gram-positive and gram-negative sepsis.

Avail customized purchase options for your needs

Microbiology Technology to Witness Attractive Growth between 2017 and 2026

Compared to the various technologies, microbiology is likely to show attractive growth between 2017 and 2026. Microbiology technology is projected to reach nearly US$ 300 million revenue by 2026 end.

It helps in identifying microorganisms for sepsis diagnosis and quantitative detection through culture media tests. Meanwhile, molecular diagnostics is also gaining traction in the market. Factors contributing to the growth of molecular diagnostics are accurate results and low turnaround time.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global sepsis diagnostics market through 2026, which include

  • Abionic SA
  • Biomérieux SA
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.
  • Quidel Corporation
  • Becton
  • Dickinson and Company
  • Luminex Corporation
  • Abbott Laboratories Inc.
  • Qiagen NV
  • T2 Biosystems Inc.
  • Roche Holdings AG (Roche Diagnostics Limited)
  • Danaher Corporation (Beckman Coulter, Inc.).

An Adaptive Approach to Modern-day Research Needs

Market Taxonomy

Product Type
  • Blood Culture Media
  • Instrument
  • Assays & Reagents
  • Conventional Diagnostics
  • Automated Diagnostics
  • Gram-negative Bacterial Sepsis
  • Gram-positive Bacterial Sepsis
  • Fungal Sepsis
  • Other Pathogens
  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Other Technology

Sepsis Diagnostics Market Scope Of The Report

Sepsis is a body’s reaction to infection, it may develop from any type of infection. Increasing prevalence of sepsis is leading to an increasing need for early diagnosis.

Hence, the demand for related diagnostic products is also anticipated to increase.

In response to the increasing demand and need, the manufacturers of diagnostic products are also investing in the research and development of new products.

This Fact.MR report analyzes the expansion of global sepsis diagnostics market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.


The scope of Fact.MR’s report is to analyze the global sepsis diagnostics market for the forecast period 2017-2026 and provide readers an unbiased and accurate analysis.

Medical device manufacturers, research institutes, and raw material suppliers in the global sepsis diagnostics market can benefit from the analysis offered in this report.

This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to sepsis diagnostics.


The report commences with a brief information of the global sepsis diagnostics market. This executive summary sets the tone for the rest of the report, providing users the scope of the report.

The executive summary includes important facts and statistics on the global sepsis diagnostics market.


The next section offers an overview of the global sepsis diagnostics market. This comprises an introduction to the market, along with a standard definition of the product – sepsis diagnostics.

In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives.

Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global sepsis diagnostics market, the report provides updates about market opportunities, which can benefit leading manufacturers of sepsis diagnostics.

With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for sepsis diagnostics manufacturers to formulate key business strategies.

Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

Considering the broad scope of the global sepsis diagnostics market, the report by Fact.MR provides key insights and segmentation analysis and forecast.

The global sepsis diagnostics market is segmented into product type, method, pathogen, technology, and region.

The segment-wise analysis also provides detailed country-wise forecast by taking into account all the key parameters of the global sepsis diagnostics market.

The report’s last section comprises of the global sepsis diagnostics market competitive landscape, to provide readers with the dashboard view of company analysis and market players.

This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global sepsis diagnostics market.

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research.

We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

  • Primary research
  • Secondary research
  • Trade research
  • Focused interviews
  • Social media analysis

Need an Exclusive Report for your Unique Requirement?

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report on the radiation proctitis treatment industry has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.